ArticleBMJ open2024

Efficacy and safety of tirofiban in patients with acute branch atheromatous disease-related stroke (BRANT): a protocol for a randomised controlled trial.

Shengde Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.